Main text
Pluripotent stem cells (PSCs) preferentially rely on glycolytic metabolism, despite the relatively limited efficiency in energy output compared to oxidative metabolism (reviewed in (Ryall et al., 2015) ). Several explanations for this counterintuitive regulation have been put forth, including the need to increase the biosynthetic pathways through the pentose phosphate pathway (PPP) to accommodate biomass requirements in rapidly cycling cells and the necessity to prevent genomic damage caused by free radicals generated as by-products of mitochondrial oxidative phosphorylation (OXPHOS). Moreover, glycolysis-derived metabolites may represent important modulators of stem cell epigenetics (Ryall et al., 2015) .
Consequently, a dramatic glycolytic shift occurs during cell fate conversion (from somatic cells to PSCs or from PSCs to differentiated progenies (Prigione et al., 2010) . Two new papers in Cell Stem Cell and Cell Reports (Gu et al., 2016; Zhang et al., 2016) employ metabolic flux analysis to demonstrate that PSCs, even while maintaining pluripotency, dynamically modulate their glycolytic metabolism in response to changes in the culture conditions or conversion between different PSC states. Gu et al. (2016) investigated the metabolic changes occurring during the transition between human naïve and primed pluripotent states. These two PSC states respectively represent pre-implantation cells in the inner cell mass and post-implantation cells in the epiblast (Takashima et al., 2014; Theunissen et al., 2014) . Previous studies demonstrated that human and mouse naïve PSCs contain mitochondria with more immature morphology than primed PSCs (Zhou et al., 2012) . At the same time, human and mouse naïve PSCs exhibit increased OXPHOS (Takashima et al., 2014; Zhou et al., 2012) . Now Gu et al. (2016) demonstrate that human naïve PSCs, both newly derived and those cultured in previously reported reversion conditions (Takashima et al., 2014; Theunissen et al., 2014) , in addition to higher mitochondrial oxygen consumption also display elevated glycolytic rates. Human naïve PSCs consumed more glucose, produced more lactate, and incorporated more glucose carbons into lactate and into purine and pyrimidine nucleotides, implying increased flux towards glycolysis and the PPP. This is in contrast with the reduction of glycolytic metabolism previously found in mouse naïve PSCs (Zhou et al., 2012) . Gu et al. (2016) suggest that this discrepancy may be due to species-related differences. In particular, they observed that nuclear C-MYC, which promotes glucose metabolism, is higher in primed PSCs in mice, while it is higher in naïve PSCs in humans. Accordingly, using RNA-Seq analysis, Gu et al. (2016) identified significant enrichment of MYC-regulated gene sets in human naïve versus primed PSCs.
The concomitant raise of OXPHOS and glycolysis observed by Gu et al. (2016) might be a consequence of the bivalent metabolic state of naïve PSCs, which can switch to one or the other metabolic route according to the demand (Zhou et al., 2012) . In fact, it has been suggested that glycolysis may represent the basal energy source for naïve PSCs and mitochondrial respiration their spare capacity (Carbognin et al., 2016) . Accordingly, inhibition of glycolysis is not as detrimental for naïve PSCs as it is for primed PSCs (Takashima et al., 2014) . It would be interesting to compare the effects of OXPHOS inhibition. Perhaps, naïve and primed PSCs would equally survive as they both rely on glycolysis. Overall, naïve PSCs appear equipped with a metabolic program that enables efficient adaption to different environmental conditions, including those not favorable for glycolysis, which might also partially explain their enhanced clonogenic properties.
Signaling molecules and culture conditions play a contributing role in the primed to naïve conversion. LIF is employed in the majority of naïve media (Gu et al., 2016; Takashima et al., 2014) and activates mitochondrial respiration (Carbognin et al., 2016) . Activin is included in some naïve media (Gu et al., 2016; Theunissen et al., 2014) and may stimulate glycolysis through the stabilization of Hypoxia-Inducible Factor-1 alpha (HIF1a) (Zhou et al., 2012) . HIF1a is a master metabolic regulator contributing to the glycolytic shift associated with the induction of pluripotency (Prigione et al., 2014) 
